Send Inquiry

Request To Call Back

Cipla Lopimune Tablets

Name: Cipla Lopimune Tablets
Brand: M/S ITRADE EXIM
Price: 2717.0 INR
Availability: InStock

Price 2717.0 INR/ Bottle

Get a Price/Quote

MOQ : 10 Bottles

Cipla Lopimune Tablets Specification

Pacakaging (Quantity Per Box)
60 tablets

Appearance
Orange film-coated tablets

Origin of Medicine
India

Medicine Type
Antiretroviral

Grade
Pharmaceutical

Salt Composition
Lopinavir and Ritonavir

CAS No
192725-17-0, 155213-67-5

Expiration Date
36 months from manufacture Months

Dosage Form
Tablet

Assay
Lopinavir 200mg, Ritonavir 50mg

Storage
Store below 30C, protect from moisture

Indication
For use with other antiretrovirals in HIV-1

Dosage
One tablet twice daily or as prescribed

Molecular Formula
Lopinavir: C37H48N4O5, Ritonavir: C37H48N6O5S2

Usage
Treatment of HIV infection

Strength
250mg per tablet

Route
Oral

Film Coating
Yes

Shelf Life
36 months

WHO GMP
Yes

Tablet Color
Orange

Packaging Type
HDPE bottle

Brand Name
Cipla Lopimune

Cipla Lopimune Tablets Trade Information

Minimum Order Quantity
10 Bottles

Supply Ability
1000 Bottles Per Month

Delivery Time
7 Days

Packaging Details
Cipla s Lopimune tablets are typically supplied in a standard pharmaceutical bottle or box packaging containing 60 tablets per pack. Tablets are sealed within a container, which is then usually housed in a cardboard box.

Cipla Lopimune Tablets About

Procure the valorous new release from Cipla - Lopimune Tablets, designed for optimum efficacy in the management of HIV-1 infection. Each orange, film-coated tablet contains a synergistic blend of Lopinavir (200mg) and Ritonavir (50mg), and comes in a secure HDPE bottle (60 tablets per box). Proudly manufactured in India following WHO GMP standards, this pharmaceutical-grade antiretroviral offers a majestic 36-month shelf life. Get it now and experience optimum reliability, supported by Cipla's dedication to global health innovation.

Competitive Advantage & Applications of Cipla Lopimune Tablets

Cipla Lopimune Tablets stand out through their optimum combination of Lopinavir and Ritonavir, offering valorous defense against HIV-1 infection. Ideal for routine general use with other antiretrovirals, they can also serve specific regimens outlined by healthcare providers. The tablets' robust shelf life and precise formulation ensure efficacy in a variety of clinical settings, making them a preferred choice among healthcare professionals. Other applications may extend to long-term antiretroviral protocols as advised by clinicians.

Supply Capability, Packaging & Certifications for Cipla Lopimune Tablets

With reliable delivery and consistent supply, Cipla ensures global exchange for Lopimune Tablets, available directly from India. Each drop-off features meticulously packaged orange film-coated tablets in HDPE bottles that safeguard product integrity throughout transit. Certified by WHO GMP, every batch upholds pharmaceutical excellence. Supply capabilities meet large-scale export, and all deliveries comply with rigorous quality and safety standards, giving partners and patients confidence in every transaction.

FAQ's of Cipla Lopimune Tablets:

Q: How should Cipla Lopimune Tablets be taken for best results?

A: Lopimune Tablets are intended for oral administration, typically one tablet twice daily or as directed by your healthcare provider. It is essential to follow the prescribed dosage to ensure maximum efficacy.

Q: What are the principal benefits of Cipla Lopimune Tablets in HIV therapy?

A: The combination of Lopinavir and Ritonavir in Cipla Lopimune Tablets offers an optimum therapeutic effect, helping to control HIV-1 infection when used with other antiretrovirals, reducing viral load and improving immune function.

Q: When do Cipla Lopimune Tablets expire and how should they be stored?

A: Cipla Lopimune Tablets have a shelf life of 36 months from the date of manufacture. They should be stored below 30C and protected from moisture to maintain potency.

Q: Where are Cipla Lopimune Tablets manufactured?

A: These tablets are produced in India by Cipla, in facilities that comply with WHO Good Manufacturing Practice (GMP) standards.

Q: What packaging is available for Cipla Lopimune Tablets?

A: Lopimune Tablets are provided in HDPE bottles, each containing 60 orange film-coated tablets, ensuring product stability and easy transport during delivery or drop-off.

Q: What certification ensures the quality of Cipla Lopimune Tablets?

A: Every batch of Lopimune Tablets is manufactured under WHO GMP certification, ensuring pharmaceutical grade quality and safety for patients worldwide.

Tell us about your requirement